EFFECTS OF 2 NEW ALDOSE REDUCTASE INHIBITORS, AL-1567 AND AL-1576, IN DIABETIC RATS

被引:45
作者
GRIFFIN, BW
MCNATT, LG
CHANDLER, ML
YORK, BM
机构
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1987年 / 36卷 / 05期
关键词
D O I
10.1016/0026-0495(87)90048-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:486 / 490
页数:5
相关论文
共 28 条
[1]  
CHANDLER M L, 1982, Investigative Ophthalmology and Visual Science, V22, P156
[2]  
CHANDLER ML, 1984, INVEST OPHTHALMOL S, V25, P159
[3]   DIABETIC NEUROPATHY - NEW CONCEPTS OF ITS ETIOLOGY [J].
CLEMENTS, RS .
DIABETES, 1979, 28 (06) :604-611
[4]   POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR [J].
DVORNIK, D ;
SIMARDDU.N ;
KRAMI, M ;
SESTANJ, K ;
GABBAY, KH ;
KINOSHITA, JH ;
VARMA, SD ;
MEROLA, LO .
SCIENCE, 1973, 182 (4117) :1146-1148
[5]   PURIFICATION AND IMMUNOLOGICAL IDENTIFICATION OF ALDOSE REDUCTASES [J].
GABBAY, KH ;
CATHCART, ES .
DIABETES, 1974, 23 (05) :460-468
[6]  
GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609
[7]  
Gabbay KH, 1973, ADV METAB DISORD S, V2, P417
[8]   CHARACTERIZATION OF THE REDUCTION OF 3-ACETYLPYRIDINE ADENINE-DINUCLEOTIDE PHOSPHATE BY BENZYL ALCOHOL CATALYZED BY ALDOSE REDUCTASE [J].
GRIFFIN, BW ;
MCNATT, LG .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1986, 246 (01) :75-81
[9]  
GRIFFIN BW, 1984, INVEST OPHTHALMOL S2, V25, P136
[10]  
GRIFFIN BW, IN PRESS 3RD INT WOR